Harmony Biosciences Holdings (HRMY) Other Non Operating Income (2020 - 2026)
Harmony Biosciences Holdings (HRMY) reported Other Non Operating Income of -$79000.0 for Q1 2026, up 71.38% on a YoY basis from -$46097.3 in Q1 2025, and down 106.67% sequentially from $1.2 million in Q4 2025.
Harmony Biosciences Holdings (HRMY) Other Non Operating Income (2020 - 2026) Analysis & Trends
Harmony Biosciences Holdings (HRMY) has 7 years of Other Non Operating Income data on file, last reported at -$79000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 71.38% year-over-year to -$79000.0; the trailing twelve-month figure through Mar 2026 stood at $807000.0 (up 497.54% YoY), and the FY2025 full-year result was $610000.0, up 997.06% from the prior year.
- Other Non Operating Income eased to -$79000.0 in Q1 2026, from $1.2 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.2 million in Q4 2025 to a low of -$9.8 million in Q3 2023.
- A 5-year average of -$572687.5 and a median of -$16500.0 in 2022 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income jumped 950.0% in 2022 and plunged 17539.29% in 2023, its largest moves.
- Tracing HRMY's Other Non Operating Income over 5 years: stood at $73000.0 in 2022, then plunged by 13478.08% to -$9.8 million in 2023, then soared by 101.64% to $160000.0 in 2024, then jumped by 640.62% to $1.2 million in 2025, then plunged by 106.67% to -$79000.0 in 2026.
- Business Quant data shows HRMY's Other Non Operating Income at -$79000.0 in Q1 2026, $1.2 million in Q4 2025, and -$106000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Harmony Biosciences Holdings | 2.07 Bn | 1.55 Bn | 170.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79,000.00 |
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | -106,000.00 |
| Jun 30, 2025 | -193,000.00 |
| Mar 31, 2025 | -276,000.00 |
| Dec 31, 2024 | 160,000.00 |
| Sep 30, 2024 | -124,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Mar 31, 2024 | -141,000.00 |
| Sep 30, 2023 | -9.77 Mn |
| Jun 30, 2023 | -31,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2022 | 73,000.00 |
| Sep 30, 2022 | 56,000.00 |
| Jun 30, 2022 | 42,000.00 |
| Mar 31, 2022 | -2,000.00 |
| Sep 30, 2021 | -26.15 Mn |
| Jun 30, 2021 | 4,000.00 |
| Mar 31, 2021 | -20,000.00 |
| Sep 30, 2020 | -1.53 Mn |